Castle Biosciences (CSTL) Competitors $19.78 -0.24 (-1.20%) Closing price 04:00 PM EasternExtended Trading$19.77 -0.01 (-0.05%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CSTL vs. ARDT, PGNY, AGL, PACS, ADUS, TDOC, NHC, AHCO, VRDN, and GRALShould you be buying Castle Biosciences stock or one of its competitors? The main competitors of Castle Biosciences include Ardent Health Partners (ARDT), Progyny (PGNY), agilon health (AGL), PACS Group (PACS), Addus HomeCare (ADUS), Teladoc Health (TDOC), National HealthCare (NHC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), and Grail (GRAL). These companies are all part of the "healthcare" industry. Castle Biosciences vs. Ardent Health Partners Progyny agilon health PACS Group Addus HomeCare Teladoc Health National HealthCare AdaptHealth Viridian Therapeutics Grail Ardent Health Partners (NYSE:ARDT) and Castle Biosciences (NASDAQ:CSTL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends. Do analysts rate ARDT or CSTL? Ardent Health Partners currently has a consensus target price of $21.18, indicating a potential upside of 63.95%. Castle Biosciences has a consensus target price of $38.75, indicating a potential upside of 95.90%. Given Castle Biosciences' higher possible upside, analysts clearly believe Castle Biosciences is more favorable than Ardent Health Partners.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ardent Health Partners 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00Castle Biosciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to ARDT or CSTL? In the previous week, Ardent Health Partners had 5 more articles in the media than Castle Biosciences. MarketBeat recorded 12 mentions for Ardent Health Partners and 7 mentions for Castle Biosciences. Ardent Health Partners' average media sentiment score of 0.93 beat Castle Biosciences' score of 0.85 indicating that Ardent Health Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health Partners 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Castle Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation and earnings, ARDT or CSTL? Ardent Health Partners has higher revenue and earnings than Castle Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArdent Health Partners$5.97B0.31$53.90MN/AN/ACastle Biosciences$332.07M1.67-$57.47M$0.6231.90 Does the MarketBeat Community favor ARDT or CSTL? Castle Biosciences received 71 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 87.50% of users gave Ardent Health Partners an outperform vote while only 64.79% of users gave Castle Biosciences an outperform vote. CompanyUnderperformOutperformArdent Health PartnersOutperform Votes2187.50% Underperform Votes312.50%Castle BiosciencesOutperform Votes9264.79% Underperform Votes5035.21% Is ARDT or CSTL more profitable? Castle Biosciences has a net margin of 1.95% compared to Ardent Health Partners' net margin of 0.00%. Castle Biosciences' return on equity of 1.47% beat Ardent Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets Ardent Health PartnersN/A N/A N/A Castle Biosciences 1.95%1.47%1.27% Do insiders & institutionals hold more shares of ARDT or CSTL? 92.6% of Castle Biosciences shares are held by institutional investors. 7.2% of Castle Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryCastle Biosciences beats Ardent Health Partners on 8 of the 14 factors compared between the two stocks. Remove Ads Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CSTL vs. The Competition Export to ExcelMetricCastle BiosciencesMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$553.98M$2.81B$5.54B$7.86BDividend YieldN/A24.76%5.35%4.05%P/E Ratio98.9013.1423.4218.67Price / Sales1.67184.01367.9087.32Price / CashN/A57.5638.1634.64Price / Book1.364.226.634.09Net Income-$57.47M-$22.21M$3.20B$246.93M7 Day Performance-5.09%-7.15%-6.42%-3.78%1 Month Performance-8.76%-2.09%-1.56%-6.74%1 Year Performance-11.10%-4.47%7.14%-1.88% Castle Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CSTLCastle Biosciences2.2238 of 5 stars$19.78-1.2%$38.75+95.9%-9.6%$553.98M$332.07M98.90540ARDTArdent Health PartnersN/A$13.30+1.2%$21.18+59.2%N/A$1.90B$5.97B0.0024,200Analyst ForecastNews CoverageGap DownPGNYProgyny1.3363 of 5 stars$22.05+0.9%$24.82+12.6%-41.4%$1.88B$1.17B38.02310Analyst UpgradeNews CoverageAGLagilon health0.9181 of 5 stars$4.47-1.4%$3.95-11.4%-29.1%$1.84B$6.06B-4.75650Positive NewsPACSPACS Group3.8397 of 5 stars$11.91+3.5%$34.00+185.5%N/A$1.82B$3.56B0.0032,433Options VolumeNews CoverageADUSAddus HomeCare4.7815 of 5 stars$90.98+1.3%$132.78+45.9%-4.3%$1.65B$1.15B20.8233,200Positive NewsTDOCTeladoc Health3.0596 of 5 stars$8.86+5.3%$11.26+27.2%-47.2%$1.54B$2.57B-1.535,100NHCNational HealthCareN/A$91.46+0.8%N/AN/A$1.41B$1.30B11.4612,400Positive NewsAHCOAdaptHealth3.5183 of 5 stars$10.39+4.0%$13.80+32.8%-5.8%$1.40B$3.26B-6.3010,900Positive NewsVRDNViridian Therapeutics1.2389 of 5 stars$15.46+1.3%$35.70+130.9%-23.0%$1.26B$302,000.00-3.5950Positive NewsGRALGrail0.769 of 5 stars$32.13+6.1%$20.00-37.8%N/A$1.09B$125.60M0.001,360Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies Ardent Health Partners Alternatives Progyny Alternatives agilon health Alternatives PACS Group Alternatives Addus HomeCare Alternatives Teladoc Health Alternatives National HealthCare Alternatives AdaptHealth Alternatives Viridian Therapeutics Alternatives Grail Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CSTL) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CSTL Stock Free CSTL Stock Alerts